tacrine has been researched along with ximelagatran in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Andersson, TB; Ekroos, K; Forsberg, GB; Lagadic-Gossmann, D; Lefeuvre-Orfila, L; Oscarsson, J; Rissel, M; Sergent, O | 1 |
3 other study(ies) available for tacrine and ximelagatran
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Ximelagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes.
Topics: Anticoagulants; Azetidines; Benzylamines; Cell Line; Cell Membrane; Hepatocytes; Humans; Membrane Fluidity; Membrane Lipids; Tacrine | 2009 |